Questions and Ambiguities [BE/BA News]

posted by d_labes  – Berlin, Germany, 2011-03-28 16:16 (4334 d 07:43 ago) – Posting: # 6822
Views: 32,043

Dear Helmut,

❝ Period ratios (second / first administration):

❝ Type 3: SAS according to R-doc - 2 outliers (#46: 3.524, #45: 26.08)

❝ Type 5: or is this SAS? - 2 outliers

❝ Type 6: Minitab, SPSS, Phoenix/WinNonlin - 2 outliers

❝ ...


SAS has 5 different percentile definitions. The default is:
Let n*p=j+g where j is the integer part, g is the fractional part, n is the number of values, x the ordered values.
Let y denote the percentile. Then (SAS PCTLDEF=5)
  y = 0.5*(xj+xj+1) if g=0
  y = xj           if g>0

This corresponds to R's Type 2 I think.

❝ Don’t know what to do. :confused: Suggestions?


If the 'outlier' considerations based on the crippled EMA model makes any sense at all, which I'm not convinced at all :no:, I would vote for an analysis of the residuals, not the period ratios also they appeared a natural choice on the first view.
Pro's:Con's:But these Con's are unavoidable because of the EMA 'model', whatever here is modelled.
To add more ambiguities:

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
24 visitors (0 registered, 24 guests [including 9 identified bots]).
Forum time: 23:00 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5